Marfan Syndrome with CRHD
Marfan syndrome (MFS) is an inheritable disorder caused by mutation of fibrillin-1 gene. It is the most common disorder among disorders of connective tissue. Its mode of inheritance is autosomal dominant. The reported prevalence of this disorder is one in three thousand (3000) to five (5000) thousand individuals. It presents with varied manifestation and different range of severity. The organ systems most commonly affected by this disorder include eyes, cardiovascular system, and musculoskeletal system.
The other systems which may be affected include respiratory system, skin, and central nervous system. It is diagnosed with the help of revised Ghent score which includes a set of various diagnostic criteria which need to be fulfilled. MFS in this patient was diagnosed after the fulfillment of the revised Ghent score criteria, which included a positive history of MFS in the family and a systemic score of 8.
In this case report, we are reporting a case of MFS which is unusual and remarkable in the sense that it is associated with chronic rheumatic heart disease (CRHD), and not the cardiovascular features which are usually present in cases of MFS. We tried to find a similar case if ever reported previously and, after extensive search, we could find only few cases   of MFS which were associated with CRHD.
17. Dezember 2020 (online)
© 2020. Women in Cardiology and Related Sciences. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India
- 1 Ramirez F, Godfrey M, Leeo B. et al. Marfan syndrome and related disorders. In: Scriver CR, Beaudet AL, Sly WS. et al., eds. the Metabolic and Molecular Basis of Inherited Disease. New York: McGraw Hill; 1995: 4079
- 2 Judge DP, Dietz HC. Marfan’s syndrome. Lancet 2005; 366 (9501) 1965-1976
- 3 Loeys BL, Dietz HC, Braverman AC. et al. The revised Ghent nosology for the Marfan syndrome. J Med Genet 2010; 47 (07) 476-485
- 4 Aldrich HR, Labarre RL, Roman MJ, Rosen SE, Spitzer MC, Devereux RB. Color flow and conventional echocardiography of the Marfan syndrome. Echocardiography 1992; 9 (06) 627-636
- 5 Dormand H, Mohiaddin RH. Cardiovascular magnetic resonance in Marfan syndrome. J Cardiovasc Magn Reson 2013; 15: 33
- 6 Pyeritz RE, Wappel MA. Mitral valve dysfunction in the Marfan syndrome. Clinical and echocardiographic study of prevalence and natural history. Am J Med 1983; 74 (05) 797-807
- 7 Morse RP, Rockenmacher S, Pyeritz RE. et al. Diagnosis and management of infantile marfan syndrome. Pediatrics 1990; 86 (06) 888-895
- 8 Schroeyers P, Wellens F, Degrieck I. et al. Aggressive primary treatment for poststernotomy acute mediastinitis: our experience with omental- and muscle flaps surgery. Eur J Cardiothorac Surg 2001; 20 (04) 743-746
- 9 Stheneur C, Faivre L, Collod-Béroud G. et al. Prognosis factors in probands with an FBN1 mutation diagnosed before the age of 1 year. Pediatr Res 2011; 69 (03) 265-270
- 10 Fujiseki Y, Okuno K, Tanaka M, Shimada M, Takahashi M, Kawanishi K. Myocardial involvement in the Marfan syndrome. Jpn Heart J 1985; 26 (06) 1043-1050
- 11 Alpendurada F, Wong J, Kiotsekoglou A. et al. Evidence for Marfan cardiomyopathy. Eur J Heart Fail 2010; 12 (10) 1085-1091
- 12 Abd El Rahman M, Haase D, Rentzsch A. et al. Left ventricular systolic dysfunction in asymptomatic Marfan syndrome patients is related to the severity of gene mutation: insights from the novel three dimensional speckle tracking echocardiography. PLoS One 2015; 10 (04) e0124112
- 13 Nagesh CM, Patra S, Singh A, Badnur SC, Reddy B, Nanjappa MC. A patient with Marfan’s syndrome presented with severe rheumatic mitral stenosis and successfully treated with percutaneous transmitral balloon commissurotomy - Report of first case. J Cardiovasc Dis Res 2013; 4 (04) 257-259
- 14 Olawale MA, Abiola M, Adeseye AA, Oladimeji GO. Rheumatic heart disease in a patient with Marfan’s syndrome. International Journal of Case Reports and Images 2019; (e-pub ahead of print) DOI: 10.5348/101020Z01OA2019CR.
- 15 Kumar PR, Manik G, Azam MS. Severe rheumatic mitral stenosis in marfanoid young man successfully managed with percutaneous mitral balloon valvotomy. Journal of Case Reports 2016; 6 (03) 338-341